Treatment of benign prostatic hyperplasia through transurethral needle ablation (TUNA™) -: Review of the literature and six years of clinical experience

被引：20
|
作者：
Braun, M
Mathers, M
Bondarenko, B
Engelmann, U
机构：
[1] Univ Cologne, Dept Urol, DE-50924 Cologne, Germany
[2] Dept Urol, Remscheid, Germany
来源：
UROLOGIA INTERNATIONALIS | 2004年 / 72卷 / 01期
关键词：
transurethral needle ablation of the prostate; BPH; long-term results;
D O I：
10.1159/000075270
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Following FDA clearance and the establishment of Medicare coverage, transurethral needle ablation ( TUNA) has become an established and widely-adopted treatment method for BPH in the USA. Germany is lagging behind at present, though a change can also be recognized there. The lack of long-term data has often been criticized. This review presents an overview of clinical outcomes of TUNA, long-term results and patient selection criteria. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码：32 / 39
页数：8
相关论文
共 50 条
  • [21] Evaluation of outcome of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia: A 10-year experience
    Haroun, Hossam
    Eltatawy, Hassan
    Soliman, M. C.
    Tawfik, Ahmed
    Ragab, M. M.
    Ramadan, Ahmed
    Sabaa, Magdy
    UROLOGY ANNALS, 2019, 11 (02) : 198 - 203
  • [22] A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia
    Bruskewitz, R
    Issa, MM
    Roehrborn, CG
    Naslund, MJ
    Perez-Marrero, R
    Shumaker, BP
    Oesterling, JE
    JOURNAL OF UROLOGY, 1998, 159 (05): : 1588 - 1593
  • [23] TRANSURETHRAL NEEDLE ABLATION (TUNA) - THERMAL-GRADIENT MAPPING AND COMPARISON OF LESION SIZE IN A TISSUE MODEL AND IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
    RASOR, JS
    ZLOTTA, AR
    EDWARDS, SD
    SCHULMAN, CC
    EUROPEAN UROLOGY, 1993, 24 (03) : 411 - 414
  • [24] TRANSURETHRAL MICROWAVE THERMOTHERAPY FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA - PRELIMINARY EXPERIENCE
    VANCAUWELAERT, RR
    CASTILLO, OC
    AQUIRRE, CA
    AZOCAR, GH
    MEDINA, FI
    EUROPEAN UROLOGY, 1993, 23 (02) : 282 - 284
  • [25] A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia
    Boyle, P
    Robertson, C
    Vaughan, ED
    Fitzpatrick, JM
    BJU INTERNATIONAL, 2004, 94 (01) : 83 - 88
  • [26] A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia - Comment
    Lepor, H
    JOURNAL OF UROLOGY, 1998, 159 (05): : 1593 - 1594
  • [27] The economics of benign prostatic hyperplasia treatment: A literature review
    Kortt, MA
    Bootman, JL
    CLINICAL THERAPEUTICS, 1996, 18 (06) : 1227 - 1241
  • [28] TRANSURETHRAL MICROWAVE HYPERTHERMIA FOR BENIGN PROSTATIC HYPERPLASIA - THE LEUVEN CLINICAL-EXPERIENCE
    BAERT, L
    AMEYE, F
    ASTRAHAN, M
    PETROVICH, Z
    JOURNAL OF ENDOUROLOGY, 1993, 7 (01) : 61 - 69
  • [29] An open study on the efficacy and safety of transurethral needle ablation of the prostate in treating symptomatic benign prostatic hyperplasia: The University of Florida experience
    Kahn, SA
    Alphonse, P
    Tewari, A
    Narayan, P
    JOURNAL OF UROLOGY, 1998, 160 (05): : 1695 - 1700
  • [30] 12 months clinical outcomes of Transurethral UltraSound Ablation (TULSA) for benign prostatic hyperplasia
    Anttinen, M. H. J.
    Viitala, A.
    Doerwald, P.
    Maekelae, P.
    Nurminen, P.
    Paerssinen, H.
    Sainio, T.
    Virtanen, I.
    Taimen, P.
    Sequeiros, R. Blanco
    Bostroem, P. J.
    EUROPEAN UROLOGY, 2023, 83 : S340 - S340
12345